Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deubiquitinases in hematological malignancies
Hu Lei, Jiaqi Wang, Jiacheng Hu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Ubiquitin-specific peptidase 10 promotes renal interstitial fibrosis progression through deubiquitinating and stabilizing P53 protein
Suwen Liu, Yunwen Yang, Qian Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167660-167660
Closed Access
BRISC inactivation alleviates alcohol-induced liver injury in mice
Ting Wang, Wen Zhang, Xian Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma
Mengjie Guo, Meng Han, Y. Henry Sun, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 5
Open Access
JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression
Hu Lei, Li Yang, Yingying Wang, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Ubiquitin specific peptidases and prostate cancer
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen, et al.
PeerJ (2023) Vol. 11, pp. e14799-e14799
Open Access | Times Cited: 10
Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
H. N. Abramson
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2645-2645
Open Access | Times Cited: 9
Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression
Liang Wu, Zili Zhou, Yang Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 3
Targeting the ubiquitin pathway in lymphoid malignancies
Boheng Li, Pieter J.A. Eichhorn, Wee Joo Chng
Cancer Letters (2024) Vol. 594, pp. 216978-216978
Open Access | Times Cited: 3
The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer
Svitlana Antonenko, М.П. Завелевич, Г. Д. Телегеев
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 8
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
Jill V. Hunter, A. Campbell, Nicola Hannaway, et al.
Biochemical Journal (2022) Vol. 479, Iss. 19, pp. 2063-2086
Open Access | Times Cited: 9
Role of UCHL3 in health and disease
Hu Lei, Hanzhang Xu, Yingli Wu
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150626-150626
Closed Access | Times Cited: 1
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
Martin H. Kastnes, Kristin Roseth Aass, Siri Anshushaug Bouma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients
Farhad Zamani, Solmaz Khalighfard, Mohammad Reza Kalhori, et al.
Medical Oncology (2023) Vol. 40, Iss. 10
Open Access | Times Cited: 3
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia
Maja Jankovic, William W. L. Poon, Cristobal Gonzales-Losada, et al.
Blood Advances (2024) Vol. 8, Iss. 20, pp. 5315-5329
Open Access
Discovery of N-Benzylpiperidinol derivatives as USP7 inhibitors against Hematology
Youlu Pan, Haifeng Chen, Jingfeng Fu, et al.
Bioorganic Chemistry (2024), pp. 107807-107807
Closed Access
Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis
Fang Qiu, Yuntong Li, Lile Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Peer Review #3 of "Ubiquitin specific peptidases and prostate cancer (v0.1)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen, et al.
(2023)
Open Access
Peer Review #2 of "Ubiquitin specific peptidases and prostate cancer (v0.1)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen, et al.
(2023)
Open Access
Peer Review #1 of "Ubiquitin specific peptidases and prostate cancer (v0.1)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen, et al.
(2023)
Open Access
Peer Review #3 of "Ubiquitin specific peptidases and prostate cancer (v0.2)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen, et al.
(2023)
Open Access
Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients
Farhad Zamani, Solmaz Khalighfard, Mohammad Reza Kalhori, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top